Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024)

Curis' (CRIS) quarterly Change in Acquisitions & Divestments came in at -$428000.0 in Q4 2024, down 102.12% YoY from $20.2 million in Q1 2024, and down 102.34% on a QoQ basis from $18.3 million in Q3 2024.

Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024) Analysis & Trends

Curis (CRIS) has 15 years of Change in Acquisitions & Divestments data on file, last reported at -$428000.0 in Q4 2024.

  • Quarterly Change in Acquisitions & Divestments fell 102.12% year-over-year to -$428000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$428000.0 (down 100.63% YoY) and the FY2024 annual result came in at $47.5 million, down 56.03% from the prior year.
  • Change in Acquisitions & Divestments eased to -$428000.0 in Q4 2024, from $18.3 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $43.9 million in Q1 2023 to a low of -$428000.0 in Q4 2024.
  • A 5-year average of $17.7 million and a median of $18.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 112600.0% — and 2024, when it tumbled 102.12%.
  • Tracing CRIS's Change in Acquisitions & Divestments over 5 years: stood at -$4000.0 in 2020, then jumped by 465725.0% to $18.6 million in 2021, then slipped by 13.86% to $16.0 million in 2022, then gained by 25.91% to $20.2 million in 2023, then plunged by 102.12% to -$428000.0 in 2024.
  • The last three Change in Acquisitions & Divestments figures came in at -$428000.0 (Q4 2024), $18.3 million (Q3 2024), and $29.6 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Curis 3.27 Mn -2.35 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -428,000.00
Dec 31, 2024 -428,000.00
Sep 30, 2024 18.32 Mn
Sep 30, 2024 18.32 Mn
Mar 31, 2024 29.65 Mn
Mar 31, 2024 29.65 Mn
Dec 31, 2023 20.20 Mn
Dec 31, 2023 20.20 Mn
Sep 30, 2023 36.50 Mn
Sep 30, 2023 36.50 Mn
Jun 30, 2023 7.50 Mn
Jun 30, 2023 7.50 Mn
Mar 31, 2023 43.93 Mn
Mar 31, 2023 43.93 Mn
Dec 31, 2022 16.04 Mn
Dec 31, 2022 16.04 Mn
Sep 30, 2022 18.00 Mn
Sep 30, 2022 18.00 Mn
Jun 30, 2022 39.50 Mn
Jun 30, 2022 39.50 Mn